Cited by 2,543SARS-CoV-2 and COVID-19 ResearchGenomics and Phylogenetic StudiesSARS-CoV-2 detection and testing

The DOI matches its Crossref record; 16 of the 18 references it cites were found in a registry or an index.

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Open access

Rambaut, Andrew, Holmes, Edward C., O’Toole, Áine, Hill, Verity, McCrone, John T., Ruis, Christopher, du Plessis, Louis, Pybus, Oliver G.·2020·Nature Microbiology

DOI 10.1038/s41564-020-0770-5PMC PMC7610519

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

The ongoing pandemic spread of a new human coronavirus, SARS-CoV-2, which is associated with severe pneumonia/disease (COVID-19), has resulted in the generation of tens of thousands of virus genome sequences. The rate of genome generation is unprecedented, yet there is currently no coherent nor accepted scheme for naming the expanding phylogenetic diversity of SARS-CoV-2. Here, we present a rational and dynamic virus nomenclature that uses a phylogenetic framework to identify those lineages that contribute most to active spread. Our system is made tractable by constraining the number and depth of hierarchical lineage labels and by flagging and delabelling virus lineages that become unobserved and hence are probably inactive. By focusing on active virus lineages and those spreading to new locations, this nomenclature will assist in tracking and understanding the patterns and determinants of the global spread of SARS-CoV-2.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41564-020-0770-5

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform
Katoh, K. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf436 · Cited by 17,027
IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era
Minh, B. Q., Schmidt, H. A., Chernomor, O., Schrempf, D., Woodhams, M. D., von Haeseler, A., & Lanfear, R. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa015 · Cited by 16,873
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Self-citation
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
Self-citation
Ultrafast Approximation for Phylogenetic Bootstrap
Minh, B. Q., Nguyen, M. A. T., & von Haeseler, A. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst024 · Cited by 4,844
GISAID: Global initiative on sharing all influenza data – from vision to reality
Shu, Y., & McCauley, J. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.13.30494 · Cited by 3,039
Maximum likelihood phylogenetic estimation from DNA sequences with variable rates over sites: Approximate methods.
Yang, Z. (1994) · Journal of Molecular Evolution · doi:10.1007/bf00160154 · Cited by 2,960
Untitled work
(1986) · Cited by 2,570
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
Smith, D. B., Bukh, J., KUIKEN, C. L., Muerhoff, A. S., Rice, C. M., Stapleton, J. T., & Peter Simmonds, K. (2013) · Hepatology · doi:10.1002/hep.26744 · Cited by 1,352

Show all 18 references

Sorted by citations

Items 101–200 of 1,013

Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA
Earnest, R., Uddin, R., Matluk, N. N., Renzette, N., Turbett, S. E., Siddle, K. J., Loreth, C., Adams, G. C., Tomkins-Tinch, C. H., Petrone, M. E., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100583 · Cited by 199
Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2
O'Toole, Á., Hill, V., Pybus, O. G., Watts, A., Bogoch, I. I., Khan, K., Messina, J. P., The COVID-19 Genomics UK (COG-UK) consortium, Network for Genomic Surveillance in South Africa (NGS-SA), Brazil-UK CADDE Genomic Network, et al. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16661.1 · Cited by 192
Self-citation
Cold-chain food contamination as the possible origin of COVID-19 resurgence in Beijing
Pang, X., Ren, L., Wu, S., Ma, W., Yang, J., Di, L., Li, J., Xiao, Y., Kang, L., Du, S., et al. (2020) · National Science Review · doi:10.1093/nsr/nwaa264 · Cited by 210
Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants — United States, June 2021–January 2022
Lambrou, A. S., Shirk, P., Steele, M. K., Paul, P., Paden, C. R., Cadwell, B. L., Reese, H. E., Aoki, Y., Hassell, N., Zheng, X.-Y., et al. (2022) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7106a4 · Cited by 202
Relative instantaneous reproduction number of Omicron SARS‐CoV‐2 variant with respect to the Delta variant in Denmark
Ito, K., Piantham, C., & Nishiura, H. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27560 · Cited by 204
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants
Dearlove, B. L., Lewitus, É., Bai, H., Li, Y., Reeves, D. B., Joyce, M. G., Scott, P. T., Amare, M. F., Vasan, S., Michael, N. L., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008281117 · Cited by 206
Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir
Ullrich, S., Ekanayake, K. B., Otting, G., & Nitsche, C. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128629 · Cited by 197
Tracking the COVID-19 pandemic in Australia using genomics
Seemann, T., Lane, C. R., Sherry, N. L., Duchêne, S., da Silva, A. G., Caly, L., Sait, M. L., Ballard, S. A., Horan, K., Schultz, M. B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18314-x · Cited by 197
Untangling introductions and persistence in COVID-19 resurgence in Europe
Lemey, P., Ruktanonchai, N., Hong, S. L., Colizza, V., Poletto, C., den Broeck, F. V., Gill, M. S., Ji, X., Levasseur, A., Munnink, B. B. O., et al. (2021) · Nature · doi:10.1038/s41586-021-03754-2 · Cited by 178
A Recurrent Mutation at Position 26340 of SARS-CoV-2 Is Associated with Failure of the E Gene Quantitative Reverse Transcription-PCR Utilized in a Commercial Dual-Target Diagnostic Assay
Artesi, M., Bontems, S., Göbbels, P., Franckh, M., Maes, P., Boreux, R., Meex, C., Melin, P., Hayette, M., Bours, V., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.01598-20 · Cited by 195
Transmission of SARS-CoV-2 (Variant Delta) from Pet Hamsters to Humans and Onward Human Propagation of the Adapted Strain: A Case StudyPreprint
Yen, H., Sit, T. H. C., Brackman, C. J., Chuk, S. S., Gu, H., Tam, K. W. S., Law, P. Y.-T., Leung, G. M., Peiris, M., Poon, L. L. M., et al. (2022) · SSRN Electronic Journal · doi:10.1016/s0140-6736(22)00326-9 · Cited by 210
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
Lazarević, I., Pravica, V., Miljanovic, D., & Cupic, M. D. (2021) · Viruses · doi:10.3390/v13071192 · Cited by 193
Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections
Farinholt, T., Doddapaneni, H., Qin, X., Menon, V. K., Meng, Q., Metcalf, G., Chao, H., Gingras, M., Avadhanula, V., Farinholt, P., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02103-4 · Cited by 185
The Evolution and Biology of SARS-CoV-2 VariantsPreprint
Telenti, A., Hodcroft, E. B., & Robertson, D. L. (2022) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041390 · Cited by 191
Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?
Hashemian, S. M. R., Sheida, A., Taghizadieh, M., Memar, M. Y., Hamblin, M. R., Baghi, H. B., Nahand, J. S., Asemi, Z., & Mirzaei, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114367 · Cited by 184
Wastewater SARS-CoV-2 monitoring as a community-level COVID-19 trend tracker and variants in Ohio, United States
Ai, Y., Davis, A., Jones, D. R., Lemeshow, S. A., Tu, H., He, F., Ru, P., Pan, X., Bohrerova, Z., & Lee, J. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.149757 · Cited by 174
Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use
Rockett, R. J., Basile, K., Maddocks, S., Fong, W., Agius, J. E., Johnson-Mackinnon, J., Arnott, A., Chandra, S., Gall, M., Draper, J. L., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmc2120219 · Cited by 171
High-throughput sequencing of SARS-CoV-2 in wastewater provides insights into circulating variants
Fontenele, R. S., Kraberger, S. J., Hadfield, J., Driver, E. M., Bowes, D. A., Holland, L. A., Faleye, T. O. C., Adhikari, S., Kumar, R., Inchausti, R., et al. (2021) · Water Research · doi:10.1016/j.watres.2021.117710 · Cited by 167
Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages
Xia, S., Wang, L., Zhu, Y., Lu, L., & Jiang, S. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01105-9 · Cited by 167
Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: A retrospective cohort study
Hay, J. A., Kissler, S. M., Fauver, J. R., Mack, C. D., Tai, C. G.-L., Samant, R. M., Connolly, S., Anderson, D. J., Khullar, G., MacKay, M. J., et al. (2022) · eLife · doi:10.7554/elife.81849 · Cited by 172
Accommodating individual travel history and unsampled diversity in Bayesian phylogeographic inference of SARS-CoV-2
Lemey, P., Hong, S., Hill, V., Baele, G., Poletto, C., Colizza, V., O'Toole, Á., McCrone, J., Andersen, K., Worobey, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18877-9 · Cited by 153
Self-citation
Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
Servellita, V., Syed, A. M., Morris, M. K., Brazer, N., Saldhi, P., Garcia-Knight, M., Sreekumar, B. K. N., Khalid, M. M., Ciling, A., Chen, P., et al. (2022) · Cell · doi:10.1016/j.cell.2022.03.019 · Cited by 155
Genomic surveillance to combat COVID-19: challenges and opportunities
Robishaw, J. D., Alter, S. M., Solano, J. J., Shih, R. D., DeMets, D. L., Maki, D. G., & Hennekens, C. H. (2021) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00121-x · Cited by 154
SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines
Thakur, S., Sasi, S., Pillai, S. G., Nag, A., Shukla, D., Singhal, R., Phalke, S., & Velu, G. S. K. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.815389 · Cited by 167
Phylogenetic Analysis of SARS-CoV-2 Data Is Difficult
Morel, B., Barbera, P., Czech, L., Bettisworth, B., Hübner, L., Lutteropp, S., Serdari, D., Kostaki, E. G., Mamais, I., Kozlov, A. M., et al. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa314 · Cited by 176
Emergence and Expansion of the SARS-CoV-2 Variant B.1.526 Identified in New York
Annavajhala, M. K., Mohri, H., Wang, P., Nair, M., Zucker, J. E., Sheng, Z., Gomez-Simmonds, A., Kelley, A. L., Tagliavia, M., Huang, Y., et al. (2021) · doi:10.1101/2021.02.23.21252259
Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Spike mutation T478K
Giacomo, S. D., Mercatelli, D., Rakhimov, A. N., & Giorgi, F. M. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27062 · Cited by 159
Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
Ramesh, S., Govindarajulu, M., Parise, R. S., Neel, L. T., Shankar, T., Patel, S., Lowery, P., Smith, F., Dhanasekaran, M., & Moore, T. (2021) · Vaccines · doi:10.3390/vaccines9101195 · Cited by 157
Phylogenetic and phylodynamic approaches to understanding and combating the early SARS-CoV-2 pandemic
Attwood, S. W., Hill, S. C., Aanensen, D. M., Connor, T. R., & Pybus, O. G. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00483-8 · Cited by 154
Self-citation
New nomenclature for mpox (monkeypox) and monkeypox virus clades
Ulaeto, D., Агафонов, А. В., Burchfield, J., Carter, L., Happi, C. T., Jakob, R., Krpelanová, E., Kuppalli, K., Lefkowitz, E. J., Mauldin, M. R., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00055-5 · Cited by 152
Self-citation
Neutralising antibody escape of SARS‐CoV‐2 spike protein: Risk assessment for antibody‐based Covid‐19 therapeutics and vaccines
Focosi, D., & Maggi, F. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2231 · Cited by 150
Transmission of SARS-CoV-2 from humans to animals and potential host adaptation
Tan, C. C. S., Lam, S. D., Richard, D., Owen, C. J., Berchtold, D., Orengo, C. A., Nair, M. S., Kuchipudi, S. V., Kapur, V., van Dorp, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30698-6 · Cited by 154
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States
Tenforde, M. W., Patel, M. M., Ginde, A. A., Douin, D. J., Talbot, H. K., Casey, J. D., Mohr, N. M., Zepeski, A. E., Gaglani, M., McNeal, T., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab687 · Cited by 243
Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection
Teo, A. K. J., Choudhury, Y., Tan, I. B., Cher, C. Y., Chew, S. H., Wan, Z. Y., Cheng, L. T., Oon, L. L. E., Tan, M. H., Chan, K. S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-82787-z · Cited by 148
Interferon resistance of emerging SARS-CoV-2 variants
Guo, K., Barrett, B. S., Morrison, J. H., Mickens, K. L., Vladar, E. K., Hasenkrug, K. J., Poeschla, E. M., & Santiago, M. L. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2203760119 · Cited by 141
Pandemic-scale phylogenomics reveals the SARS-CoV-2 recombination landscape
Turakhia, Y., Thornlow, B. P., Hinrichs, A. S., McBroome, J., Ayala, N., Ye, C., Smith, K., Maio, N. D., Haussler, D. H., Lanfear, R., et al. (2022) · Nature · doi:10.1038/s41586-022-05189-9 · Cited by 148
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs
Weingarten-Gabbay, S., Klaeger, S., Sarkizova, S., Pearlman, L. R., Chen, D.-Y., Gallagher, K. M. E., Bauer, M. R., Taylor, H. B., Dunn, W. A., Tarr, C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.05.046 · Cited by 147
High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next-generation sequencing
Bhoyar, R. C., Jain, A. K., Sehgal, P., Divakar, M. K., Sharma, D., Imran, M., Jolly, B., Ranjan, G., Rophina, M., Sharma, S., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247115 · Cited by 140
The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
Hill, V., du Plessis, L., Peacock, T. P., Aggarwal, D., Colquhoun, R., Carabelli, A. M., Ellaby, N. A. F., Gallagher, E., Groves, N., Jackson, B., et al. (2022) · Virus Evolution · doi:10.1093/ve/veac080 · Cited by 145
Self-citation
Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation
Charre, C., Ginévra, C., Sabatier, M., Regue, H., Destras, G., Brun, S., Burfin, G., Scholtès, C., Morfin, F., Valette, M., et al. (2020) · Virus Evolution · doi:10.1093/ve/veaa075 · Cited by 145
SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98
Addetia, A., Lieberman, N. A. P., Phung, Q., Hsiang, T.-Y., Xie, H. J., Roychoudhury, P., Shrestha, L., Loprieno, M. A., Huang, M.-L. W., Gale, M., et al. (2021) · mBio · doi:10.1128/mbio.00065-21 · Cited by 143
Climate change, its impact on emerging infectious diseases and new technologies to combat the challenge
Liao, H., Lyon, C. J., Ying, B., & Hu, Y. (2024) · Emerging Microbes & Infections · doi:10.1080/22221751.2024.2356143 · Cited by 167
Evolutionary trajectory of SARS-CoV-2 and emerging variants
Singh, J., Pandit, P., McArthur, A. G., Banerjee, A., & Mossman, K. L. (2021) · Virology Journal · doi:10.1186/s12985-021-01633-w · Cited by 150
Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research
Hufsky, F., Lamkiewicz, K., Almeida, A., Aouacheria, A., Arighi, C. N., Bateman, A. G., Baumbach, J., Beerenwinkel, N., Brandt, C., Cacciabue, M., et al. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa232 · Cited by 141
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Sun, C., Xie, C., Bu, G., Zhong, L., & Zeng, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01039-2 · Cited by 149
Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers
dos Santos, L. A., Filho, P. G. D. G., Silva, A. M. F., dos Santos, J. V. G., Santos, D. S., Aquino, M. M., de Jesus, R. M., Almeida, M. L. D., Silva, J. S., Altmann, D. M., et al. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.01.020 · Cited by 136
Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
Becker, M., Dulovic, A., Junker, D., Ruétalo, N., Kaiser, P. D., Pinilla, Y. T., Heinzel, C., Häring, J., Traenkle, B., Wagner, T. R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23473-6 · Cited by 137
Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021
Kang, M., Xin, H., Yuan, J., Ali, S. T., Liang, Z., Zhang, J., Hu, T., Lau, E. H. Y., Zhang, Y., Zhang, M., et al. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.10.2100815 · Cited by 139
Two Years into the COVID-19 Pandemic: Lessons Learned
da Silva, S. J. R., do Nascimento, J. C. F., Mendes, R. P. G., Guarines, K. M., da Silva, C. T. A., da Silva, P. G., de Magalhães, J. J. F., Vigar, J. R. J., Silva‐Júnior, A., Kohl, A., et al. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00204 · Cited by 155
A Comparative Analysis of SARS-CoV-2 Antivirals Characterizes 3CL pro Inhibitor PF-00835231 as a Potential New Treatment for COVID-19
de Vries, M., Mohamed, A., Prescott, R. A., Valero-Jimenez, A. M., Desvignes, L., O’Connor, R., Steppan, C. M., Devlin, J. C., Ivanova, E. N., Herrera, A. M., et al. (2021) · Journal of Virology · doi:10.1128/jvi.01819-20 · Cited by 137
Surveillance of SARS-CoV-2 at the Huanan Seafood Market
Gao, G. F., Liu, P., Liu, P., Lei, W., Jia, Z., He, X., Liu, L.-L., Shi, W., Tan, Y., 邹淑梅, et al. (2023) · Nature · doi:10.1038/s41586-023-06043-2 · Cited by 136
Pango lineage designation and assignment using SARS-CoV-2 spike gene nucleotide sequences
O’Toole, Á., Pybus, O. G., Abram, M. E., Kelly, E. J., & Rambaut, A. (2022) · BMC Genomics · doi:10.1186/s12864-022-08358-2 · Cited by 146
Self-citation
Real-time genomic surveillance for enhanced control of infectious diseases and antimicrobial resistance
Struelens, M. J., Ludden, C., Werner, G., Sintchenko, V., Jokelainen, P., & Ip, M. (2024) · Frontiers in Science · doi:10.3389/fsci.2024.1298248 · Cited by 162
Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland
Filipe, A. D. S., Shepherd, J. G., Williams, T., Hughes, J., Aranday-Cortés, E., Asamaphan, P., Ashraf, S., Balcazar, C. E., Brunker, K., Campbell, A., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00838-z · Cited by 120
Self-citation
Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies
Lee, C. Y., Shah, M. K., Hoyos, D., Solovyov, A., Douglas, M., Taur, Y., Maslak, P. G., Babady, N. E., Greenbaum, B., Kamboj, M., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1033 · Cited by 133
SARS‐CoV‐2 variants and vulnerability at the global level
Chavda, V. P., Patel, A., & Vaghasiya, D. D. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27717 · Cited by 135
An 81-Nucleotide Deletion in SARS-CoV-2 ORF7a Identified from Sentinel Surveillance in Arizona (January to March 2020)
Holland, L. A., Kaelin, E. A., Maqsood, R., Estifanos, B., Wu, L. I., Varsani, A., Halden, R. U., Hogue, B. G., Scotch, M., & Lim, E. S. (2020) · Journal of Virology · doi:10.1128/jvi.00711-20 · Cited by 130
Intra-host variation and evolutionary dynamics of SARS-CoV-2 populations in COVID-19 patients
Wang, Y., Wang, D., Zhang, L., Sun, W., Zhang, Z., Chen, W., Zhu, A., Huang, Y., Xiao, F., Yao, J., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00847-5 · Cited by 124
Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome
Merenstein, C., Liang, G., Whiteside, S. A., Güemes, A. G. C., Merlino, M. S., Taylor, L. J., Glascock, A. L., Bittinger, K. L., Tanes, C., Graham-Wooten, J., et al. (2021) · mBio · doi:10.1128/mbio.01777-21 · Cited by 133
A Dual Barcoding Approach to Bacterial Strain Nomenclature: Genomic Taxonomy of Klebsiella pneumoniae Strains
Hennart, M., Guglielmini, J., Bridel, S., Maiden, M. C. J., Jolley, K. A., Criscuolo, A., & Brisse, S. (2022) · Molecular Biology and Evolution · doi:10.1093/molbev/msac135 · Cited by 128
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429Preprint
McCallum, M., Bassi, J., Marco, A. D., Chen, A., Walls, A. C., di Iulio, J., Tortorici, M. A., Navarro, M.-J., Silacci-Fregni, C., Saliba, C., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.31.437925 · Cited by 128
Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19
Zhang, J., Ejikemeuwa, A., Gerzanich, V., Nasr, M., Tang, Q., Simard, J. M., & Zhao, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.854567 · Cited by 138
Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation
Chen, D. W., Chin, C. V., Kenney, D., Tavares, A. H., Khan, N., Conway, H. L., Liu, G., Choudhary, M. C., Gertje, H. P., O’Connell, A. K., et al. (2023) · Nature · doi:10.1038/s41586-023-05697-2 · Cited by 148
Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum
Bates, T. A., Leier, H. C., Lyski, Z. L., McBride, S. K., Coulter, F. J., Weinstein, J. B., Goodman, J. R., Lu, Z., Siegel, S. A. R., Sullivan, P. D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25479-6 · Cited by 115
GenSLMs: Genome-scale language models reveal SARS-CoV-2 evolutionary dynamics
Zvyagin, M., Brace, A., Hippe, K., Deng, Y., Zhang, B., Bohorquez, C. O., Clyde, A., Kale, B., Perez-Rivera, D., Ma, H., et al. (2023) · The International Journal of High Performance Computing Applications · doi:10.1177/10943420231201154 · Cited by 120
Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis
Thye, A. Y.-K., Law, J. W., Pusparajah, P., Letchumanan, V., Chan, K., & Lee, L. (2021) · Biomedicines · doi:10.3390/biomedicines9101303 · Cited by 121
Adaptation, spread and transmission of SARS-CoV-2 in farmed minks and associated humans in the Netherlands
Lu, L., Sikkema, R. S., Velkers, F. C., Nieuwenhuijse, D. F., Fischer, E. A. J., Meijer, P. A., Bouwmeester-Vincken, N., Rietveld, A., Wegdam-Blans, M. C. A., Tolsma, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27096-9 · Cited by 128
Knowledge of Human Monkeypox and Its Relation to Conspiracy Beliefs among Students in Jordanian Health Schools: Filling the Knowledge Gap on Emerging Zoonotic Viruses
Sallam, M., Al-Mahzoum, K., Dardas, L. A., Al‐Tammemi, A. B., Al-Majali, L., Al-Naimat, H., Jardaneh, L., AlHadidi, F., Al‐Salahat, K., Al-Ajlouni, E., et al. (2022) · Medicina · doi:10.3390/medicina58070924 · Cited by 126
GenSLMs: Genome-scale language models reveal SARS-CoV-2 evolutionary dynamics
Zvyagin, M., Brace, A., Hippe, K., Deng, Y., Zhang, B., Bohorquez, C. O., Clyde, A., Kale, B., Perez-Rivera, D., Ma, H., et al. (2022) · doi:10.1101/2022.10.10.511571 · Cited by 120
Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy
Alteri, C., Cento, V., Piralla, A., Costabile, V., Tallarita, M., Colagrossi, L., Renica, S., Giardina, F., Novazzi, F., Gaiarsa, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20688-x · Cited by 118
SARS-CoV-2: Evolution and Emergence of New Viral Variants
Flores-Vega, V. R., Monroy-Molina, J. V., Jiménez-Hernández, L. E., Torres, A. G., Santos, J. I., & Rosales-Reyes, R. (2022) · Viruses · doi:10.3390/v14040653 · Cited by 127
Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters
Abdelnabi, R., Boudewijns, R., Foo, C. S.-Y., Seldeslachts, L., Sánchez-Felipe, L., Zhang, X., Delang, L., Maes, P., Kaptein, S. J. F., Weynand, B., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103403 · Cited by 103
Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection
Chaguza, C., Hahn, A. M., Petrone, M. E., Zhou, S., Ferguson, D. J. P., Breban, M. I., Pham, K., Peña-Hernández, M. A., Castaldi, C., Hill, V., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100943 · Cited by 123
Self-citation
Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages — United States, January 2022–May 2023
Ma, K. C., Shirk, P., Lambrou, A. S., Hassell, N., Zheng, X.-Y., Payne, A. B., Ali, A. R., Batra, D. G., Caravas, J., Chau, R., et al. (2023) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7224a2 · Cited by 117
SARS-CoV-2 RBD in vitro evolution follows contagious mutation spread, yet generates an able infection inhibitor
Zahradník, J., Marciano, S., Shemesh, M., Zoler, E., Chiaravalli, J., Meyer, B., Rudich, Y., Dym, O., Elad, N., & Schreiber, G. (2021) · doi:10.1101/2021.01.06.425392 · Cited by 458
SARS-CoV-2 Variant Delta Rapidly Displaced Variant Alpha in the United States and Led to Higher Viral Loads
Bolze, A., Luo, S., White, S. J., Cirulli, E. T., Wyman, D., Rossi, A. D., Machado, H., Cassens, T., Jacobs, S., Barrett, K. M. S., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100564 · Cited by 115
Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis
Chen, X., Chen, Z., Azman, A. S., Sun, R., Lu, W., Zheng, N., Zhou, J., Wu, Q., Deng, X., Zhao, Z., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab646 · Cited by 113
Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study
Adams, K., Rhoads, J. P., Surie, D., Gaglani, M., Ginde, A. A., McNeal, T., Talbot, H. K., Casey, J. D., Zepeski, A., Shapiro, N. I., et al. (2022) · BMJ · doi:10.1136/bmj-2022-072065 · Cited by 115
Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil
Francisco, R. D. S., Benites, L. F., Lamarca, A. P., de Almeida, L. G. P., Hansen, A. W., Gularte, J. S., Demoliner, M., Gerber, A. L., Guimarães, A. P. D. C., Eisen, A. K. A., et al. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198345 · Cited by 110
Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study
de Souza, W. M., Amorim, M. R., Sesti‐Costa, R., Coimbra, L. D., Brunetti, N. S., de Toledo-Teixeira, D. A., de Souza, G. F., Muraro, S. P., Parise, P. L., Barbosa, P. P., et al. (2021) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00129-4 · Cited by 115
Self-citation
The origin and early spread of SARS-CoV-2 in Europe
Nadeau, S. A., Vaughan, T. G., Scire, J., Huisman, J. S., & Stadler, T. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012008118 · Cited by 93
Stability of SARS-CoV-2 phylogenies
Turakhia, Y., Maio, N. D., Thornlow, B. P., Gozashti, L., Lanfear, R., Walker, C. R., Hinrichs, A. S., Fernandes, J. D., Borges, R., Slodkowicz, G., et al. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1009175 · Cited by 102
Infection with SARS‐CoV‐2 variant B.1.1.7 detected in a group of dogs and cats with suspected myocarditis
Ferasin, L., Fritz, M., Ferasin, H., Becquart, P., Corbet, S., Gouilh, M. A., Legros, V., & Leroy, E. M. (2021) · Veterinary Record · doi:10.1002/vetr.944 · Cited by 113
Toward a global virus genomic surveillance network
Hill, V., Githinji, G., Vogels, C. B. F., Bento, A. I., Chaguza, C., Carrington, C. V. F., & Grubaugh, N. D. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.03.003 · Cited by 113
Self-citation
Emergence in late 2020 of multiple lineages of SARS-CoV-2 Spike protein variants affecting amino acid position 677Preprint
Hodcroft, E. B., Domman, D., Snyder, D. J., Oguntuyo, K. Y., Diest, M. V., Densmore, K. H., Schwalm, K. C., Femling, J., Carroll, J. L., Scott, R. S., et al. (2021) · medRxiv · doi:10.1101/2021.02.12.21251658 · Cited by 110
The Global Landscape of SARS-CoV-2 Genomes, Variants, and Haplotypes in 2019nCoVR
Song, S., Ma, L., Zou, D., Tian, D., Li, C., Zhu, J., Chen, M., Wang, A., Ma, Y., Li, M., et al. (2020) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2020.09.001 · Cited by 105
Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda
Bugembe, D. L., Phan, M. V. T., Ssewanyana, I., Semanda, P., Nansumba, H., Dhaala, B., Nabadda, S. N., O’Toole, Á., Rambaut, A., Kaleebu, P., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00933-9 · Cited by 104
Self-citation
A clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airways
Lorenzo-Redondo, R., Nam, H. H., Roberts, S. C., Simons, L. M., Jennings, L. J., Qi, C., Achenbach, C. J., Hauser, A. R., Ison, M. G., Hultquist, J. F., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103112 · Cited by 110
SARS-CoV-2 Causes Severe Epithelial Inflammation and Barrier Dysfunction
Deinhardt‐Emmer, S., Böttcher, S., Häring, C., Giebeler, L. N., Henke, A., Zell, R., Jungwirth, J., Jordan, P. M., Werz, O., Hornung, F., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00110-21 · Cited by 114
COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interest
Chen, A. T., Altschuler, K., Zhan, S. H., Chan, Y. A., & Deverman, B. E. (2021) · eLife · doi:10.7554/elife.63409 · Cited by 116
Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New Zealand
Geoghegan, J. L., Ren, X., Storey, M., Hadfield, J., Jelley, L., Jefferies, S., Sherwood, J., Paine, S., Huang, Q. S., Douglas, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20235-8 · Cited by 120
Self-citation
Possible future waves of SARS-CoV-2 infection generated by variants of concern with a range of characteristics
Dyson, L., Hill, E. M., Moore, S., Curran-Sebastian, J. L., Tildesley, M. J., Lythgoe, K., House, T., Pellis, L., & Keeling, M. J. (2021) · Nature Communications · doi:10.1038/s41467-021-25915-7 · Cited by 104
Genomic reconstruction of the SARS-CoV-2 epidemic in England
Vöhringer, H. S., Sanderson, T., Sinnott, M., Maio, N. D., Nguyen, T., Goater, R., Schwach, F., Harrison, I., Hellewell, J., Ariani, C. V., et al. (2021) · Nature · doi:10.1038/s41586-021-04069-y · Cited by 108
Variants with the N501Y mutation extend SARS-CoV-2 host range to mice, with contact transmissionPreprint
Montagutelli, X., Prot, M., Levillayer, L., Baquero, E., Jouvion, G., Conquet, L., Beretta, M., Donati, F., Albert, M., Gámbaro, F., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.18.436013 · Cited by 114
Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report
Giandhari, J., Pillay, S., Wilkinson, E., Tegally, H., Sinayskiy, I., Schuld, M., Lourenço, J., Chimukangara, B., Lessells, R. J., Moosa, M. S., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.11.128 · Cited by 108
Genomic epidemiology of the SARS-CoV-2 epidemic in Brazil
Giovanetti, M., Slavov, S. N., Fonseca, V., Wilkinson, E., Tegally, H., Patané, J. S. L., Viala, V. L., San, J. E., Rodrigues, E. S., Santos, E. V., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01191-z · Cited by 109
Self-citation
Remdesivir Resistance in Transplant Recipients With Persistent Coronavirus Disease 2019
Hogan, J. I., Duerr, R., Dimartino, D., Marier, C., Hochman, S. E., Mehta, S., Wang, G., & Heguy, A. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac769 · Cited by 108
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United StatesPreprint
Tenforde, M. W., Patel, M. M., Ginde, A. A., Douin, D. J., Talbot, H. K., Casey, J. D., Mohr, N. M., Zepeski, A. E., Gaglani, M., McNeal, T., et al. (2021) · medRxiv · doi:10.1101/2021.07.08.21259776 · Cited by 108
Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines
dos Santos, W. G. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111272 · Cited by 108
Quantitative SARS-CoV-2 Viral-Load Curves in Paired Saliva Samples and Nasal Swabs Inform Appropriate Respiratory Sampling Site and Analytical Test Sensitivity Required for Earliest Viral Detection
Savela, E. S., Winnett, A. V., Romano, A. E., Porter, M. K., Shelby, N., Akana, R., Ji, J., Cooper, M. M., Schlenker, N. W., Reyes, J. A., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.01785-21 · Cited by 112

Authors: Rambaut, A., Holmes, E. C., O’Toole, Á., Hill, V., McCrone, J. T., Ruis, C., du Plessis, L., & Pybus, O. G.
Affiliations: University of Edinburgh (GB)
The University of Sydney (AU)
University of Cambridge (GB)
University of Oxford (GB)
Corresponding author: Rambaut, Andrew
Holmes, Edward C.
Pybus, Oliver G.
ORCID: Rambaut, Andrew
Holmes, Edward C.
O’Toole, Áine
Hill, Verity
McCrone, John T.
Ruis, Christopher
du Plessis, Louis
Pybus, Oliver G.
Venue: Nature Microbiology
Publisher: Springer Science and Business Media LLC
Published: 2020-07-15
Volume: 5
Issue: 11
Pages: 1403-1407
ISSN: 2058-5276 (ISSN-L)
DOI: 10.1038/s41564-020-0770-5
PMC: PMC7610519
OpenAlex: W3043124965
Cited by: 2,543
References: 18
Citations by year: 2026: 86 · 2025: 141 · 2024: 235 · 2023: 365 · 2022: 700 · 2021: 851 · 2020: 163
FWCI: 68.76
Type: journal article
Language: en
Update notices: addendum (2021-01-29)
Open access: bronze
doi.org
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Microbiology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
Funders: Wellcome Trust (206298/Z/17/Z-ARTIC, FP7/2007–2013, Z/17/Z, 206298/Z/17/Z, 206298, 725422-ReservoirDOCS)
European Commission (725422, 725422-RESERVOIRDOCS, 2007–2013, FP7 2007-2013, HORIZON2020, FP7/2007, COVID-19)
Australian Research Council (FL170100022)
FP7 Ideas: European Research Council (614725)
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
Keywords: SARS-CoV-2, COVID-19 pandemic, virus nomenclature, phylogenetic lineages, genomic epidemiology
MeSH terms: Betacoronavirus, COVID-19, SARS-CoV-2, Genotype, Humans, Phylogeny, Pneumonia, Viral, Genome, Viral, Molecular Epidemiology, Coronavirus Infections, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks